New-onset atrial fibrillation diagnosed by cardiac implantable devices in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis
Event: ESC Congress 2022
Topic: Hypertrophic Cardiomyopathy
Session: Electrocardiography and cardiomyopathies
Omecamtiv mecarbil for the management of heart failure: a meta-analysis of randomized controlled trials
Event: ESC Congress 2022
Topic: Pharmacotherapy
Session: Heart failure pharmacology
ESC 365 is supported by
